Apolipoprotein E2 (Arg136→Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia - Marz,W.; Hoffmann,M.M.; Scharnagl,H. (J Lipid Res, 1998)